Levetiracetam treatment influences blood-brain barrier failure associated with angiogenesis and inflammatory responses in the acute phase of epileptogenesis in post-status epilepticus mice
- 1 December 2016
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 1652, 1-13
Abstract
No abstract availableKeywords
Funding Information
- JSPS KAKENHI (JP16K10216, JP15K18947, JP15K08122, JP26740024)
This publication has 60 references indexed in Scilit:
- Pentylentetrazole-induced loss of blood–brain barrier integrity involves excess nitric oxide generation by neuronal nitric oxide synthaseBrain Research, 2013
- Mechanisms of cerebral edema in traumatic brain injury: therapeutic developmentsCurrent Opinion in Neurology, 2010
- Inflammatory Neurodegeneration and Mechanisms of Microglial Killing of NeuronsMolecular Neurobiology, 2010
- Epilepsy in later lifeThe Lancet Neurology, 2009
- Levetiracetam in newly diagnosed late-onset post-stroke seizures: A prospective observational studyEpilepsy Research, 2008
- Antiepileptogenesis Therapy with Levetiracetam: Data from Kindling versus Status Epilepticus ModelsEpilepsy Currents, 2007
- Prophylactic treatment with levetiracetam after status epilepticus: Lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in ratsNeuropharmacology, 2007
- The Antiepileptic Drug Levetiracetam Decreases the Inositol 1,4,5-Trisphosphate-Dependent [Ca2+]i Increase Induced by ATP and Bradykinin in PC12 CellsThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Antiepileptic Drug Pharmacokinetics and Interactions: Impact on Treatment of EpilepsyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000
- The Pilocarpine Model of Epilepsy in MiceEpilepsia, 1996